Lipocalin-2 expression in papillary thyroid carcinoma and its association with clinicopathological characteristics
- 6 September 2024
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (1) , 451-456
Abstract
Purpose The present study aimed to assess Lipocalin-2 (LCN2) expression in patients with papillary thyroid cancer (PTC) and to compare it with multinodular goitre (MNG). We also investigated the correlation between LCN2 expression and clinicopathologic characteristics. Methods This retrospective study included 63 surgically treated adult patients with papillary carcinoma and 65 adult patients with a MNG. Age, gender, physical, radiological and histopathological examinations, and surgical data of the patients were extracted from the hospital records. Size, histological subtype, capsule invasion, multifocality, extrathyroidal extension (ETE), lymph node metastasis (LNM), and immunohistochemical (IHC) studies of the tumour were recorded from the final histopathological reports of patients with PTC. The patient groups were compared in terms of LCN2 expression. The relationships between LCN2 expression and clinicopathological and other IHC parameters were also evaluated in patients with PTC. Results LCN2 expression was significantly higher in the PTC group than in the control group. No significant correlation was demonstrated between LCN2 expression and the presence of multifocal disease, capsular invasion, vascular invasion, ETE, and LNM. There was a moderate positive correlation between LCN2 and human bone marrow endothelial cell marker-1 (HBME-1) expressions, however, no correlation was found between LCN2 and cytokeratin-19 (CK19), CD56, and galectin-3. Conclusion LCN2 expression may be a useful biomarker in differentiating benign and malignant lesions of the thyroid gland; however, its expression pattern may not be associated with clinicopathologic characteristics of the PTC and should be investigated in further studies with larger clinical samples.Keywords
This publication has 18 references indexed in Scilit:
- Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancerEndocrine, 2024
- Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transitionAnnals of Diagnostic Pathology, 2022
- Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-UpThyroid®, 2019
- CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extensionBMC Cancer, 2018
- Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5European Journal of Cancer, 2017
- Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinomaTumor Biology, 2014
- Neutrophil Gelatinase-Associated Lipocalin in Cancer2014
- A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-upSurgery, 2013
- NGAL Controls the Metastatic Potential of Anaplastic Thyroid Carcinoma CellsThe Journal of Clinical Endocrinology & Metabolism, 2013
- The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cellsProceedings of the National Academy of Sciences, 2008